| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.0085 | 0.9 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.9 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.023 | 0.9 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.0081 | 0.9 |